Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography. 2012

Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital, Innsbruck, Austria. Angelika.Hammerer-Lercher@uki.at

BACKGROUND The determination of urinary neopterin using high performance liquid chromatography (HPLC) has routinely been performed in Innsbruck since the middle of the 1980s. The aim was to compare the HPLC method with a commercially available radioimmunoassay. METHODS Neopterin to creatinine ratios were calculated in the urine of 33 healthy volunteers (33±7.3 years) collected at eight given time points. Neopterin and creatinine were simultaneously determined by HPLC and by radioimmunoassay (RIA; BRAHMS; neopterin) and an enzymatic method (Roche; creatinine), respectively. Assays were compared with Bland-Altman plots and Passing-Bablok regression analysis. RESULTS Neopterin to creatinine ratios ranged from 62 to 490 μmol/mol (HPLC) and from 17 to 425 μmol/mol (RIA-enzymatic combined). The ratios were on average 17.3% lower using the combined RIA-enzymatic method compared to the HPLC method. Neopterin concentrations measured by RIA were only slightly lower (on average 4.9%) than by the HPLC and the regression analysis revealed a good accordance with linearity. In contrast, creatinine concentrations by the enzymatic method were on average 12.8% higher than by HPLC. CONCLUSIONS There is a marked bias between HPLC and the combined RIA-enzymatic method for measurement of urinary neopterin to creatinine ratios which has to be considered when methods are switched during the follow-up of patients.

UI MeSH Term Description Entries
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016482 Urinalysis Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically. Urinalyses
D019798 Neopterin A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of BIOPTERINS. 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone,Monapterin,Neopterin, (R*, R*)-Isomer,Neopterin, (erythro-D)-Isomer,Neopterin, (erythro-L)-Isomer,Neopterin, (threo-D)-Isomer,Neopterin, (threo-L)-Isomer,Umanopterin

Related Publications

Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
August 1989, Journal of chromatography,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
January 1987, Journal of chromatography,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
June 2004, Journal of biochemical and biophysical methods,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
June 1985, Prostaglandins, leukotrienes, and medicine,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
February 1982, Journal of chromatography,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
December 1977, Journal of chemical education,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
March 1989, Antimicrobial agents and chemotherapy,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
March 1993, Annals of clinical biochemistry,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
May 1982, Steroids,
Angelika Hammerer-Lercher, and Christina Moser, and Veronika Leichtfried, and Wolfgang Schobersberger, and Andrea Griesmacher, and Dietmar Fuchs
February 1994, Journal of chromatography. A,
Copied contents to your clipboard!